U.S. Supreme Court decision rejects Purdue Pharma opioid settlement, leaving victims in limbo

0
72

U.S. Supreme Court decision rejects Purdue Pharma opioid settlement, leaving victims in limbo

The U.S. Supreme Court on Thursday rejected a nationwide settlement with OxyContin maker Purdue Pharma that would have shielded members of the Sackler family who own the company from civil lawsuits over the toll of opioids but also would have provided billions of dollars to combat the opioid epidemic.

After deliberating more than six months, the justices in a 5-4 vote blocked an agreement hammered out with state and local governments and victims. The Sacklers would have contributed up to $6 billion US and given up ownership of the company but retained billions more. The agreement provided that the company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention.

Justice Neil Gorsuch, writing for the majority, said “nothing in present law authorizes the Sackler discharge.”

Chief Justice John Roberts and Justices Brett Kavanaugh, Elena Kagan and Sonia Sotomayor dissented.

“Today’s decision is wrong on the law and devastating for more than 100,000 opioid victims and their families,” Kavanaugh wrote.

“Opioid victims and other future victims of mass torts will suffer greatly in the wake of today’s unfortunate and destabilizing decision.”

WATCH l A recap of the arguments before the court:

U.S. Supreme Court weighs Purdue Pharma opioid settlement

7 months ago

Duration 2:01

The U.S. Supreme Court debates Oxycontin maker Purdue Pharma’s bankruptcy settlement and whether company owners, the Sackler family — who have not filed for personal bankruptcy, can be held liable for the opioid epidemic.

‘A mockery of the justice system’

The Purdue Pharma settlement would have ranked among the largest reached by drug companies, wholesalers and pharmacies to resolve epidemic-related lawsuits filed by state, local and Native American tribal governments and others.

Those settlements have totalled more than $50 billion. But the Purdue Pharma settlement would have been only the second so far to include direct payments to victims from a $750 million pool. Payouts would have ranged from about $3,500 to $48,000.

LISTEN l David Ovalle, Washington Post reporter focusing on addiction, on the case (Dec. 6, 2023): 

Front Burner22:20Will Purdue’s opioid settlement be overturned?


The high court had put the settlement on hold last summer, in response to objections from the Biden administration.

It’s unclear what happens next.

“The Purdue plan was a victim-centred plan that would provide billions of dollars to the states to be used exclusively to abate the opioid crisis and $750 million for victims of the crisis, so that they could begin to rebuild their lives,” Edward Neiger, a lawyer representing more than 60,000 overdose victims, said in a statement. “As a result of the senseless three-year crusade by the government against the plan, thousands of people died of overdose, and today’s decision will lead to more needless overdose deaths.”

A relatively small but vocal group of victims and family members opposed the settlement, including Ed Bisch, whose teen son Eddie died from an overdose after taking OxyContin in Philadelphia in 2001.

“This is a step toward justice. It was outrageous what they were trying to get away with,” said Ed Bisch, a New Jersey resident. “[The Sacklers] have made a mockery of the justice system and then they tried to make a mockery of the bankruptcy system.”

Bisch called on the U.S. Department of Justice to seek criminal charges against Sackler family members.

Sacklers no longer on company board

Arguments in early December lasted nearly two hours in a packed courtroom as the justices seemed, by turns, unwilling to disrupt a carefully negotiated settlement and reluctant to reward the Sacklers.

The issue for the justices was whether the legal shield that bankruptcy provides can be extended to people such as the Sacklers, who have not declared bankruptcy themselves. Lower courts had issued conflicting decisions over that issue, which also has implications for other major product liability lawsuits settled through the bankruptcy system.

A cleanshaven man in a suit and tie is shown raising his right hand while sitting at a desk in a still taken from video.
David Sackler, former member of the board of directors for Purdue Pharma, is sworn in to testify by video link during a congressional hearing on Dec. 17, 2020. (U.S. House Oversight Committee/Reuters)

The U.S. Bankruptcy Trustee, an arm of the Justice Department, argued that the bankruptcy law does not permit protecting the Sackler family from being sued.

During the Trump administration, the government supported the settlement. The Biden administration had argued to the court that negotiations could resume, and perhaps lead to a better deal, if the court were to stop the current agreement.

Proponents of the plan said third-party releases are sometimes necessary to forge an agreement, and federal law imposes no prohibition against them.

OxyContin first hit the market in 1996, and Purdue Pharma’s aggressive marketing of it is often cited as a catalyst of the nationwide opioid epidemic, with doctors persuaded to prescribe painkillers with less regard for addiction dangers.

The drug and the Stamford, Ct.-based company became synonymous with the crisis, even though the majority of pills being prescribed and used were generic drugs.

Opioid-related overdose deaths have continued to climb, hitting 80,000 in recent years. Most of those are from fentanyl and other synthetic drugs. 

Canada has also been hit hard by an opioid crisis, leaving to class-action suits across several provinces. B.C. in 2022 announced a $150 million Cdn settlement with Purdue Pharma Canada, on behalf of governments across Canada, to recover health-care costs related to the sale and marketing of opioid-based pain medication.

Purdue told CBC News at the time the settlement did not include an “admission of wrongdoing or liability on the part of Purdue Canada or any of its related parties.”

Sackler family members no longer are on the company’s board, and they have not received payouts from it since before Purdue Pharma entered bankruptcy. In the decade before that, though, they were paid more than $10 billion, about half of which family members said went to pay taxes.

Published at Thu, 27 Jun 2024 15:14:50 +0000

Donated Canadian-built armoured vehicles break down often, Ukrainian commander says

Ukrainian troops are learning that some of their Canadian-donated vehicles have limited usefulness close to the frontlines, a military official in the eastern part of that embattled country told CBC News.

In a recent interview near the embattled city of Kharkiv, Yuriy Fedorenko, commander of the Achilles drone unit in the Ukrainian 92nd Brigade, said the Roshel-manufactured Senator armoured cars in his unit have broken down frequently.

“It is not designed to drive off-road,” Fedorenko said, adding the vehicles seem better suited to law enforcement than combat.

“This is an option for the police, for the protection of public order, but it fulfils its task. It saves people. When there is no alternative, it is what we need.”

The Ukrainians have been driving the vehicles hard. The Senators, which look like SUVs on steroids, suffer broken springs when off-roading.

“This is more an option to go on asphalt,” Fedorenko said. “It fails quite often.”

He said Ukrainian vehicle technicians have managed to repair the Senators and keep them on the road.

Canada has donated 208 Senator vehicles to the Ukrainian military since Russia’s full-scale invasion began in February 2022. 

Andrée-Anne Poulin, a spokesperson for the Department of National Defence (DND), said the Ukrainian military has not expressed concerns about the armoured cars but acknowledged their utility near the frontlines is limited. Poulin said there were already several Senators in Ukraine’s inventory before Canada donated more of the vehicles.

“The Roshel Senator vehicles were specifically requested by the Government of Ukraine,” said Poulin in a statement issued to CBC News.

Vehicles not built for combat, DND says

She described the Senators as “security task vehicles” that are easily manoeuvrable and adaptable and carry state-of-the-art technology and weapons.

“Although these armoured vehicles are not meant for front-line combat, they enable the safe transport of personnel and equipment, and medical evacuations,” she said. “The vehicles’ armour helps to shield troops when they are unable to avoid danger.”

Roshel, the manufacturer, said in a separate statement that it has been working closely and collaboratively with the Ukrainian military.

“The conditions of a battleground are often severe. Roshel vehicles are designed and built to withstand these conditions,” said the unsigned statement from the company, which is based in Brampton, Ont.

“Our team has been on the ground from the first day of the war, recording and addressing any issues to ensure continuous improvement. This proactive approach has enabled continuous enhancements to critical vehicle components, such as axles and suspension systems, optimizing their performance across a variety of challenging terrains.”

Ukrainian commander Yuriy Fedorenko with one of the Canadian-built Senators near Kharkiv.
Ukrainian commander Yuriy Fedorenko with one of the Canadian-built Senators near Kharkiv. (Corinne Seminoff/CBC News)

Roshel has built over 1,200 vehicles that are now in service in Ukraine. Many of them were donated by European countries over and above Canada’s contribution.

“We are committed to ensuring that if challenges related to the durability of equipment arise, we immediately and continually improve our products to address those concerns and better support the men and women who put their lives on the line every day,” the company said.

Defence analyst Richard Shimooka of the Macdonald-Laurier Institute said he’s not surprised off-road reliability issues have arisen because the vehicle is relatively new and it’s getting a real baptism of fire in Ukraine.

WATCH: G7 leaders commit to $50B loan for Ukraine   

G7 leaders commit to lending Ukraine $50B US from seized Russian assets

14 days ago

Duration 1:59

Canada has agreed to contribute $5 billion US to a $50 billion US loan to help Ukraine in its fight against Russia. The U.S.-led plan involves using the interest generated from roughly 200 billion euros (about $215 billion US) in frozen Russian assets.

He pointed to the initial assessments of the U.S.-manufactured Humvee (HMMWV) 40 years ago. The patrol vehicles got less than glowing reviews at the time, but went on to become key equipment for coalition forces during the war in Iraq.

Throughout the Ukraine war, the government in Kyiv has pleaded with Canada for more heavily armoured vehicles suitable for combat.

“Clearly [the Senator] wasn’t intended to fully operate in, or around, the front line,” Shimooka said, “but it’s being pressed into that role for the lack of better options.”

He said it’s certainly a better option than the unarmoured HMMWV.

“Personally, I think the government [of Canada] should have been more proactive in getting LAVs [light armoured vehicles] over — even delaying delivery of existing orders to Canada or other countries to prioritize Ukraine,” Shimooka said.

Canada donated 39 brand-new armoured combat support vehicles to Ukraine and is in the process of buying and delivering 50 more.

Published at Thu, 27 Jun 2024 08:00:00 +0000

LEAVE A REPLY

Please enter your comment!
Please enter your name here